Publicacións (190) Publicacións nas que participase algún/ha investigador/a

2023

  1. 3D printing of PLA:CaP:GO scaffolds for bone tissue applications

    RSC Advances, Vol. 13, Núm. 23, pp. 15947-15959

  2. 8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies

    European Journal of Medicinal Chemistry, Vol. 248

  3. A Mass Spectrometry-Based Method of Quantifying the Contribution of the Lysine Polymorphism at Position 171 in Sheep PrP

    Journal of the American Society for Mass Spectrometry, Vol. 34, Núm. 2, pp. 245-254

  4. A New Opportunity for “Old” Molecules: Targeting PARP1 Activity through a Non-Enzymatic Mechanism

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  5. A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery

    Molecules, Vol. 28, Núm. 24

  6. A clinician-to-clinician universal electronic consultation programme at the cardiology department of a Galician healthcare area improves healthcare accessibility and outcomes in elderly patients

    European Heart Journal - Digital Health, Vol. 4, Núm. 2, pp. 90-98

  7. A continuous in silico learning strategy to identify safety liabilities in compounds used in the leather and textile industry

    Archives of Toxicology, Vol. 97, Núm. 4, pp. 1091-1111

  8. A crowdsourcing database for the copy-number variation of the Spanish population

    Human Genomics, Vol. 17, Núm. 1

  9. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry

    Breast cancer research : BCR, Vol. 25, Núm. 1, pp. 93

  10. A longitudinal study of free leptin index in pre-eclamptic pregnancies

    Journal of Cellular and Molecular Medicine, Vol. 27, Núm. 8, pp. 1083-1094

  11. A murine model of BSCL2-associated Celia's encephalopathy

    Neurobiology of Disease, Vol. 187

  12. A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease

    Parkinsonism and Related Disorders, Vol. 110

  13. A ready-to-use dry powder formulation based on protamine nanocarriers for pulmonary drug delivery

    European Journal of Pharmaceutical Sciences, Vol. 185

  14. A tetracationic porphyrin with dual anti-prion activity

    iScience, Vol. 26, Núm. 9

  15. AG5 is a potent non-steroidal anti-inflammatory and immune regulator that preserves innate immunity

    Biomedicine and Pharmacotherapy, Vol. 169

  16. AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability

    Brain, Behavior, and Immunity, Vol. 108, pp. 255-268

  17. Alpha-cardiac Actin Serum Expression Levels Detect Acute Cellular Rejection in Heart Transplant Patients

    Transplantation, Vol. 107, Núm. 2, pp. 466-474

  18. Antifungal Combination Eye Drops for Fungal Keratitis Treatment

    Pharmaceutics, Vol. 15, Núm. 1

  19. Antiviral Peptides Delivered by Chitosan-Based Nanoparticles to Neutralize SARS-CoV-2 and HCoV-OC43

    Pharmaceutics, Vol. 15, Núm. 6

  20. Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship

    Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454